ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†

F Cardoso¹, A Costa², L Norton³, E Senkus⁴, M Aapro⁵, F André⁶, C H Barrios⁷, J Bergh⁸, L Biganzoli⁹, K L Blackwell¹⁰, M J Cardoso¹¹, T Cufer¹², N El Saghir¹³, L Fallowfield¹⁴, D Fenech¹⁵, P Francis¹⁶, K Gelmon¹⁷, S H Giordano¹⁸, J Gligorov¹⁹, A Goldhirsch²⁰, N Harbeck²¹, N Houssami²², C Hudis²³, B Kaufman²⁴, I Krop²⁵, S Kyriakides²⁶, U N Lin²⁵, M Mayer²⁷, S D Merjaver²⁸, E B Nordström²⁹, O Pagani³⁰, A Partridge³¹, F Penault-Llorca³², M J Piccart³³, H Rugo³⁴, G Sledge³⁵, C Thomssen³⁶, L Van't Veer³⁷, D Vorobiof³⁸, C Vrieling³⁹, N West⁴⁰, B Xu⁴¹, E Winer²⁵

Affiliations

¹ European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. Electronic address: fatimacardoso@fundacaochampalimaud.pt.
² European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland.
³ Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA.
⁴ Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
⁵ Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland.
⁶ Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France.
⁷ Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil.
⁸ Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden.
⁹ Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy.
¹⁰ Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA.
¹¹ Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal.
¹² University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia.
¹³ NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon.
¹⁴ Brighton & Sussex Medical School, University of Sussex, Falmer, UK.
¹⁵ Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta.
¹⁶ Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.
¹⁷ BC Cancer Agency, Vancouver, Canada.
¹⁸ Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA.
¹⁹ APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME, Paris, France.
²⁰ Program of Breast Health, European Institute of Oncology, Milan, Italy.
²¹ Brustzentrum der Universität München, Munich, Denmark.
²² Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia.
²³ Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA.
²⁴ Sheba Medical Center, Tel Hashomer, Israel.
²⁵ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
²⁶ Europa Donna Cyprus, Nicosa, Cyprus.
²⁷ AdvancedBC.org, New York.
²⁸ University of Michigan Medical School and School of Public Health, Ann Arbor, USA.
²⁹ Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden.
³⁰ Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland.
³¹ Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA.
³² Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France.
³³ Department of Medicine, Institut Jules Bordet, Brussels, Belgium.
³⁴ Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco.
³⁵ Indiana University Medical CTR, Indianapolis, USA.
³⁶ Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany.
³⁷ Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.
³⁸ Sandton Oncology Centre, Johannesburg, South Africa.
³⁹ Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland.
⁴⁰ Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK.
⁴¹ Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

PMID: 25234545
PMCID: PMC4176456
DOI: 10.1093/annonc/mdu385

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†

F Cardoso et al. Ann Oncol. 2014 Oct.

. 2014 Oct;25(10):1871-1888.

doi: 10.1093/annonc/mdu385. Epub 2014 Sep 18.

Authors

Affiliations

¹ European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. Electronic address: fatimacardoso@fundacaochampalimaud.pt.
² European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland.
³ Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA.
⁴ Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
⁵ Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland.
⁶ Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France.
⁷ Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil.
⁸ Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden.
⁹ Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy.
¹⁰ Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA.
¹¹ Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal.
¹² University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia.
¹³ NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon.
¹⁴ Brighton & Sussex Medical School, University of Sussex, Falmer, UK.
¹⁵ Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta.
¹⁶ Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.
¹⁷ BC Cancer Agency, Vancouver, Canada.
¹⁸ Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA.
¹⁹ APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME, Paris, France.
²⁰ Program of Breast Health, European Institute of Oncology, Milan, Italy.
²¹ Brustzentrum der Universität München, Munich, Denmark.
²² Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia.
²³ Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA.
²⁴ Sheba Medical Center, Tel Hashomer, Israel.
²⁵ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
²⁶ Europa Donna Cyprus, Nicosa, Cyprus.
²⁷ AdvancedBC.org, New York.
²⁸ University of Michigan Medical School and School of Public Health, Ann Arbor, USA.
²⁹ Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden.
³⁰ Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland.
³¹ Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA.
³² Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France.
³³ Department of Medicine, Institut Jules Bordet, Brussels, Belgium.
³⁴ Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco.
³⁵ Indiana University Medical CTR, Indianapolis, USA.
³⁶ Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany.
³⁷ Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.
³⁸ Sandton Oncology Centre, Johannesburg, South Africa.
³⁹ Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland.
⁴⁰ Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK.
⁴¹ Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

PMID: 25234545
PMCID: PMC4176456
DOI: 10.1093/annonc/mdu385

No abstract available

PubMed Disclaimer

References

1. Cardoso F. Metastatic breast cancer patients: the forgotten heroes! The Breast. 2009;18:271–272. - PubMed
1. Largillier R, Ferrero J-M, Doyen J, et al. Prognostic factors in 1038 women with metastatic breast cancer. Ann Oncol. 2008;19:2012–2019. - PMC - PubMed
1. Andre F, Slimane K, Bachelot T, et al. Breast cancer with synchronous metastases: trends in survival during a 14-year period. J Clin Oncol. 2004;22:3302–3308. - PubMed
1. Sundquist M, Eriksson Z, Tejler G, et al. Trends in survival in metastatic breast cancer. Eur J Cancer. 2010;8(3):191. (abstract 453)
1. Foukakis T, Fornander T, Lekberg T, et al. Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden. Breast Cancer Res Treat. 2011;130(2):553–560. - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†

Affiliations

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†

Authors

Affiliations

References

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical